Category: BÜHLMANN Anti-ganglioside Antibodies Assay Citations

Anti-ganglioside Antibodies were not Detected in Human Subjects Infected with or Vaccinated Against 2009 Pandemic Influenza A (H1N1) Virus

Anti-GM1 Autoantibodies ELISA Citation: Lei T et al. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus. Vaccine. 2012 Mar 30; 30(16):2605-10.PMID:22342549 “Anti-ganglioside antibodies, which might be associated with the development of GBS, were previously reported to be induced in mice immunized with an H1N1

Continue Reading

The Presence of Mycoplasma Pneumoniae Infection and GM1 Ganglioside Antibodies in Guillain-Barré Syndrome

  BÜHLMANN GanglioCombi ELISA Citation: Sharma MB et al.: The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome. J Infect Dev Ctries. 2011 Jul 4; 5(6):459-64. PMID:21727645. “Significant difference in levels of anti GM1 ganglioside antibodies (IgG & IgM) was seen between GBS patients and non-neurological controls, highlighting its possible role in

Continue Reading

Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited

BÜHLMANN GanglioCombi™ MAG ELISA Citation Kollewe K et al.; Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited. PLoS One. 2015 Apr 14; 10(4):e0125339. “In the present study, we describe for the first time the utilization of a state of the art-ELISA assay to obtain reliable data on the occurrence of IgG and IgM antibodies to GA1, GM1,

Continue Reading

BÜHLMANN GanglioCombi™ MAG ELISA Utilized in Guillain-Barré Syndrome (GBS) and Zika Virus Study

The BÜHLMANN GanglioCombi™ MAG ELISA was recently utilized in a case-control study in French Polynesia focusing on individuals diagnosed with Guillain-Barré Syndrome (GBS). See publication below: Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study Learn More
Continue Reading
Sign Up for BUHLMANN Updates!

Enter your email and stay on top of things,